Insider · CIK 0001736665

BSOF Parallel Master Fund L.P.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001736665

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-10-06	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−400K sh	$17.50	−$7M	0
2021-10-05	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−23.9K sh	$19.15	−$459K	400,000
2021-10-01	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−22.6K sh	$19.13	−$432K	423,946
2021-08-23	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−352K sh	$19.00	−$6.68M	447,317
2021-08-23	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−771 sh	$20.04	−$15.5K	446,546
2021-08-18	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−3,000 sh	$15.88	−$47.6K	798,942
2021-08-12	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−10.1K sh	$13.92	−$140K	801,942
2021-08-11	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−17.2K sh	$15.03	−$259K	812,002
2021-08-03	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−22.3K sh	$14.99	−$334K	829,224
2021-08-02	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−40K sh	$15.78	−$631K	851,524
2021-07-30	PRAXPraxis Precision Medicines, Inc.S Sale	10% Owner	SSale	−15.9K sh	$15.68	−$249K	891,524
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	10% Owner	CConversion	+261K sh	—	—	7,429,277
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	10% Owner	CConversion	+907K sh	—	—	907,378
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	10% Owner	CConversion	+165K sh	—	—	7,594,109
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series A Redeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−7.38M sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series B Redeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−5.05M sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series B-1 Redeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.41M sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C Redeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−559K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C Redeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.94M sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc. · Series C-1 Redeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−353K sh	—	—	0
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	10% Owner	CConversion	+659K sh	—	—	7,167,959
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	10% Owner	CConversion	+2.36M sh	—	—	6,508,843
2020-10-20	PRAXPraxis Precision Medicines, Inc.C Conversion	10% Owner	CConversion	+3.45M sh	—	—	4,147,645

Recent filings

Accepted (ET)
Oct 84
SCHWARZMAN STEPHEN A0000899243-21-039704
SEC(opens sec.gov)
Oct 54
SCHWARZMAN STEPHEN A0000899243-21-039264
SEC(opens sec.gov)
Aug 254
SCHWARZMAN STEPHEN A0000899243-21-034149
SEC(opens sec.gov)
Aug 204
SCHWARZMAN STEPHEN A0000899243-21-033841
SEC(opens sec.gov)
Aug 134
SCHWARZMAN STEPHEN A0000899243-21-032969
SEC(opens sec.gov)
Aug 54
SCHWARZMAN STEPHEN A0000899243-21-031824
SEC(opens sec.gov)
Aug 34
SCHWARZMAN STEPHEN A0000899243-21-031302
SEC(opens sec.gov)
Oct 224
BSOF Parallel Master Fund L.P.0000899243-20-029064
SEC(opens sec.gov)

Companies

Praxis Precision Medicines, Inc.10% OwnerPRAX

Address

C/O THE BLACKSTONE GROUP INC. 345 PARK AVENUE

NEW YORK, NY, 10154